Beckman Coulter, Inc. To Host An Investor Event At The American Association for Clinical Chemistry (AACC) Annual Meeting And Clinical Lab Exposition In Chicago, Illinois

FULLERTON, Calif., July 19 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. announced today the company will host an Investor meeting on Monday, July 24, 2006, from 10:00 a.m. to 12:00 p.m. (CT) at the American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition in Chicago, Illinois. Attendees will be briefed on the company’s recently commercialized chemistry / immunoassay work cell analyzer, the UniCel(R) DxC 600i, the routine chemistry analyzers, UniCel(R) DxC 600 and 800, and the soon to be released mid-sized sample processing system, the AutoMate(TM) 800.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )

The meeting will be webcast live and is accessible to all investors through Beckman Coulter’s website at www.beckmancoulter.com or at www.streetevents.com. When accessing the webcast through the Beckman Coulter site, select “go to IR” under Investor Relations and find the meeting listed under “What’s Ahead”.

For more information on the Beckman Coulter investor meeting, please contact the Investor Relations Department at (714) 773-7620, or email: cgskoglund@beckman.com.

Other events taking place during the AACC meeting include: * AACC will host its annual IVD Industry Analyst Briefing on Monday afternoon, July 24, 2006, from 1:30 p.m. to 5:00 p.m. (CT) at the Hyatt Regency Chicago Hotel. RSVP to: Jerry Goldsmith 202 / 857-0717 or email: dkleman@aacc.org * IVD Industry Exhibits open on Tuesday, July 25 to 27, 2006 9:30a.m. - 5:00p.m. -- McCormick Place Convention Center, Chicago, Illinois * For general AACC meeting information, go to www.aacc.org.

Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing -- Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, California, reported 2005 annual sales of $ 2.44 billion with 71.5 percent of this amount generated by recurring revenue from supplies, test kits, services and operating-type lease payments. For more information, visit www.beckmancoulter.com.

Contact: Robert Raynor, (714) 773-7620, rraynor@beckman.com or

Cynthia Skoglund, (714) 773-8213, cgskoglund@beckman.com.

Photo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comBeckman Coulter, Inc.

CONTACT: Robert Raynor, +1-714-773-7620, rraynor@beckman.com, or CynthiaSkoglund, +1-714-773-8213, cgskoglund@beckman.com, both of Beckman Coulter,Inc.

MORE ON THIS TOPIC